ABCL
Price
$2.08
Change
-$0.13 (-5.86%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
661.53M
40 days until earnings call
CBUS
Price
$1.67
Change
-$0.24 (-12.57%)
Updated
Apr 3, 02:18 PM (EDT)
Capitalization
62.34M
Ad is loading...

ABCL vs CBUS

Header iconABCL vs CBUS Comparison
Open Charts ABCL vs CBUSBanner chart's image
AbCellera Biologics
Price$2.08
Change-$0.13 (-5.86%)
Volume$7.63K
Capitalization661.53M
Cibus
Price$1.67
Change-$0.24 (-12.57%)
Volume$450
Capitalization62.34M
ABCL vs CBUS Comparison Chart
Loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABCL vs. CBUS commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and CBUS is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ABCL: $2.22 vs. CBUS: $1.91)
Brand notoriety: ABCL and CBUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 100% vs. CBUS: 67%
Market capitalization -- ABCL: $661.53M vs. CBUS: $62.34M
ABCL [@Biotechnology] is valued at $661.53M. CBUS’s [@Biotechnology] market capitalization is $62.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileCBUS’s FA Score has 1 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • CBUS’s FA Score: 1 green, 4 red.
According to our system of comparison, CBUS is a better buy in the long-term than ABCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 4 TA indicator(s) are bullish while CBUS’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 4 bullish, 6 bearish.
  • CBUS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both ABCL and CBUS are a bad buy in the short-term.

Price Growth

ABCL (@Biotechnology) experienced а -8.26% price change this week, while CBUS (@Biotechnology) price change was -3.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

ABCL is expected to report earnings on May 13, 2025.

CBUS is expected to report earnings on Aug 09, 2023.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($662M) has a higher market cap than CBUS($62.3M). ABCL YTD gains are higher at: -24.232 vs. CBUS (-31.295). ABCL has higher annual earnings (EBITDA): -204.15M vs. CBUS (-492.98M). ABCL has more cash in the bank: 626M vs. CBUS (28.8M). CBUS has less debt than ABCL: CBUS (36.7M) vs ABCL (65.4M). ABCL has higher revenues than CBUS: ABCL (28.8M) vs CBUS (4.15M).
ABCLCBUSABCL / CBUS
Capitalization662M62.3M1,063%
EBITDA-204.15M-492.98M41%
Gain YTD-24.232-31.29577%
P/E RatioN/AN/A-
Revenue28.8M4.15M693%
Total Cash626M28.8M2,174%
Total Debt65.4M36.7M178%
FUNDAMENTALS RATINGS
CBUS: Fundamental Ratings
CBUS
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
21
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLCBUS
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 3 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend 22 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ABCL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COP106.100.71
+0.67%
ConocoPhillips
OFG40.140.23
+0.58%
OFG Bancorp
GAN1.770.01
+0.57%
GAN Limited
LSCC51.22-1.70
-3.21%
Lattice Semiconductor Corp
RCEL7.81-0.36
-4.41%
Avita Medical

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with ABOS. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
+4.37%
ABOS - CBUS
38%
Loosely correlated
+0.47%
ADPT - CBUS
35%
Loosely correlated
+5.59%
FHTX - CBUS
35%
Loosely correlated
+1.33%
VRDN - CBUS
35%
Loosely correlated
+4.06%
ABCL - CBUS
34%
Loosely correlated
+6.22%
More